-+ 0.00%
-+ 0.00%
-+ 0.00%

*Aethlon Medical: Phase 1a Study of NOR-101 Expected to Begin 1Q 2027, With Interim Data Expected by Mid-2027 and Phase 1b and Phase 2b Topline Data Expected in 2028 >AEMD

Dow Jones·09/17/2026 10:37:00

登录查看新闻详情